Structure/function guidance
This article was originally published in The Tan Sheet
Executive Summary
FDA seeking comments by May 23 on proposed guidance for implementing structure/function claims final reg, a Feb. 22 Federal Register notice says. Agency noted in final rule's preamble it would provide, through guidance, "examples of labeling claims that would and would not be considered disease claims under the rule, including examples of product names," notice says. FDA also invites comments on whether a guidance on citation of a publication or reference implying disease treatment or prevention is necessary. Agency notes it plans to issue a separate guidance on structure/function claims substantiation
|
FDA seeking comments by May 23 on proposed guidance for implementing structure/function claims final reg, a Feb. 22 Federal Register notice says. Agency noted in final rule's preamble it would provide, through guidance, "examples of labeling claims that would and would not be considered disease claims under the rule, including examples of product names," notice says. FDA also invites comments on whether a guidance on citation of a publication or reference implying disease treatment or prevention is necessary. Agency notes it plans to issue a separate guidance on structure/function claims substantiation. |